Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer

Author:

Fu Bin1,Wang Liyang23,Jia Tianwei456,Wei Zhao7,Nama Nuosu28,Liang Jiaqian9,Liao Xinghua10,Liu XiaMing11ORCID,Gao Yanfei12,Liu Xiaoqiang1,Mao Raymond S.13,Wang Keshan1314ORCID,Guo Ju1,Chen Shaoyong S.12

Affiliation:

1. Department of Urology The First Affiliated Hospital of Nanchang University Nanchang P.R.China

2. Department of Medicine, Hematology‐Oncology Division Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachussetts USA

3. Department of Cell Development Biology College of Life Sciences, Shaanxi Normal University Xi'an ShaanXi P.R.China

4. Department of Clinical Laboratory The Second Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P.R.China

5. Shandong Engineering & Technology Research Center for Tumor Marker Detection Jinan Shandong P.R.China

6. Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory Jinan Shandong P.R.China

7. Department of Clinical Laboratory Qilu Hospital of Shandong University Jinan Shandong P.R.China

8. Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

9. Department of Urology Wuhan No.1 Hospital Wuhan P.R.China

10. Institute of Biology and Medicine, College of Life and Health Sciences Wuhan University of Science and Technology WuHan Hubei P.R.China

11. Department of Urology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei P.R.China

12. Center for Medical Epigenetics, School of Basic Medical Sciences Chongqing Medical University Chongqing P.R.China

13. Department of Urology, Union Hospital Tongji Medical College, Huazhong University of Science and Technology Wuhan China

14. Institute of Urology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

Abstract

AbstractBackgroundThe discovery of androgen receptor (AR) having transrepression effects completes the circle of its functionalities as a typical transcription factor, which intrinsically bears dual functions of activation and repression linked to co‐factor competition and redistribution. Indeed, AR dual functions are exemplified by locus‐wide regulation of the oncogenic 8q24‐MYC region.MethodsRT‐qPCR assay and public RNA‐profiling datasets were used to assess MYC transcription in androgen‐sensitive cell lines. Public ChIP‐seq and RNA‐Seq datasets were computed to evaluate AR‐MYC direct and indirect signatures. Gene sets in typical MYC and AR pathways were monitored to validate their cross‐talks. Bio‐informatics and chromosome conformation capture (3C) assay were performed in the AR gene locus to examine androgen‐elicited distal regulation. Finally, co‐factor re‐distribution were globally tracked between AR and MYC binding sites.ResultsIn this report, we found MYC responded negatively to androgen with hypersensitivity, rivaling AR natural functions as an innate androgen effector. Furthermore, both direct and indirect AR and MYC transcriptional programs were actively in equilibration. With established androgen‐mediated versus MYC‐mediated gene subsets, we validated AR and MYC pathways were both bidirectional and extensively entangled. In addition, we determined that the AR gene locus resembled the MYC gene region and both loci were androgen‐repressed via epigenetics and chromatin architectural alterations. Significantly, transcriptional factor profiling along the prostate cancer (PCa) genome exposed that PCa transcriptomes were dynamically equilibrated between AR‐binding site and MYC‐binding site.ConclusionTogether, our findings stratified AR‐MYC interactions that are extensively wired and intricately organized to compensate for essential PCa transcriptional programs and neutralize excessive signaling.

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3